Robert Cascella Insider Profile

4 Followers
Robert Cascella, CEO & President, Director at Hologic, holds 70.98K shares in REPRO-MED Systems (Ticker: KRMD), holds 453.10K shares in Neuronetics (Ticker: STIM), holds 45.44K shares in Mirion Technologies (Ticker: MIR).
tipranks
Robert Cascella

Robert Cascella
Hologic (HOLX)
CEO & President, Director

Ranked #64,748 out of 99,218 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-7.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34M
95.70%
2.11%
1.60%
0.59%
A breakdown of Robert Cascella's holdings

Insider Roles

Hologic
(HOLX)
CEO & President, Director
Mirion Technologies
(MIR)
Director
Neuronetics
(STIM)
Director
REPRO-MED Systems
(KRMD)
Director
Roles that Robert Cascella holds in companies

Most Profitable Insider Trade

Stock:
Neuronetics
(STIM)
Rating:Informative Buy
Date:Sep 13, 2024 - Today
Return:+40.90%
The most profitable trade made by Robert Cascella

Robert Cascella's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Hologic
Jul 02, 2013
CEO & President, Director
Uninformative Sell
391.00K
$32.31M
Neuronetics
Sep 13, 2024
Director
Informative Buy
75.00K
$539.19K
Mirion Technologies
Jun 04, 2024
Director
Uninformative Buy
$713.42K
REPRO-MED Systems
Oct 01, 2024
Director
Uninformative Buy
15.00K
$199.45K
List of latest transactions for each holding click on a transaction to see Robert Cascella's performance on stock

Robert Cascella insider profile FAQ

What is the percentage of profitable transactions made by Robert Cascella?
The percentage of profitable transactions made by Robert Cascella is 43%.
    What is the average return per transaction made by Robert Cascella?
    The average return per transaction made by Robert Cascella is -7.20%.
      What stocks does Robert Cascella hold?
      Robert Cascella holds: HOLX, STIM, MIR, KRMD stocks.
        What was Robert Cascella’s latest transaction?
        Robert Cascella latest transaction was an Uninformative Buy of $15.00K.
          What was Robert Cascella's most profitable transaction?
          Robert Cascella’s most profitable transaction was an Informative Buy of STIM stock on September 13, 2024. The return on the trade was 40.90%.
            What is Robert Cascella's role in Hologic?
            Robert Cascella's role in Hologic is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.